Evidence map›Paper›PMID 35302493›Full record

ArticleeLife2022

Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs.

Charlotte Avet, Arturo Mancini, Billy Breton, Christian Le Gouill, Alexander S Hauser, Claire Normand, Hiroyuki Kobayashi, Florence Gross, Mireille Hogue, Viktoriya Lukasheva and 10 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 249 citations in OpenAlex.

  1. Innovative Approach Reveals How Receptors Control G Protein State Equilibria.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Article
  4. The structure of the dopamine DScience advances · 2026
    Article
  5. Activation of GScience advances · 2026
    Article
  6. Chemogenetic Activation of GFASEB bioAdvances · 2026
    Article
  7. Article
  8. Article
  9. G-protein regulatory network governs receptor internalization dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 4 countries.

Charlotte Avet *Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.
Arturo Mancini *Domain Therapeutics North America, Montréal, Canada.
Billy Breton *Domain Therapeutics North America, Montréal, Canada.
Christian Le Gouill *Institute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.
Alexander S Hauser *Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-1098-6419
Claire NormandDomain Therapeutics North America, Montréal, Canada.
Hiroyuki KobayashiInstitute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.ORCID 0000-0003-4965-0883
Florence GrossDomain Therapeutics North America, Montréal, Canada.
Mireille HogueInstitute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.
Viktoriya LukashevaInstitute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.
Stéphane St-OngeInstitute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.
Marilyn CarrierInstitute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.
Madeleine HérouxInstitute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.
Sandra MorissetteDomain Therapeutics North America, Montréal, Canada.
Eric B FaumanInternal Medicine Research Unit, Pfizer Worldwide Research, Development and Medical, Cambridge, United States.
Jean-Philippe FortinPfizer Global R&D, Cambridge, United States.
Stephan SchannDomain Therapeutics, Illkirch-Strasbourg, France.
Xavier LeroyDomain Therapeutics, Illkirch-Strasbourg, France.
David E GloriamDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-4299-7561
Michel BouvierInstitute for Research in Immunology and Cancer (IRIC), and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.ORCID 0000-0003-1128-0100
Institute for Research in Immunology and Cancer · CADomain Therapeutics (France) · FRPfizer (United States) · USUniversity of Copenhagen · DK

Funding

CIHR FDN-148431
6 · The paper itself

Abstract

The recognition that individual GPCRs can activate multiple signaling pathways has raised the possibility of developing drugs selectively targeting therapeutically relevant ones. This requires tools to determine which G proteins and βarrestins are activated by a given receptor. Here, we present a set of BRET sensors monitoring the activation of the 12 G protein subtypes based on the translocation of their effectors to the plasma membrane (EMTA). Unlike most of the existing detection systems, EMTA does not require modification of receptors or G proteins (except for G

Indexed as

Biosensing TechniquesGTP-Binding Proteinsbeta-Arrestin 1beta-ArrestinsHEK293 CellsHumansReceptors, G-Protein-CoupledSignal Transductionbeta-Arrestin 1beta-ArrestinsGTP-Binding ProteinsReceptors, G-Protein-Coupledbiochemistrybiosensorchemical biologyeffector membrane translocation assayenhanced bystander bioluminescence resonance energy transferG protein activationg protein-coupled receptorhigh-throughput assayhuman

Identifiers

PMID35302493
PMCPMC9005190
OpenAlexW4220763721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.